1.
Stadler N, Hasibeder A, Lopez PA, Teschner D, Desuki A, Kriege O, Weber ANR, Schulz C, Michel C, HeβG, Radsak MP. The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation. Haematologica [Internet]. 2017Apr.30 [cited 2026Nov.16];102(5):e191-e194. Available from: https://haematologica.org/article/view/8084